HDAC4 may act on UCP1 and Runx2 to alleviate the phenotypic symptoms of ALS (Vega et al., 2004; Pigna et al., 2019; Burg et al., 2021) (Figure 4). The gene discussed is HDAC4; the disease is amyotrophic lateral sclerosis.